Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,664
Total Claims
$1.7M
Drug Cost
603
Beneficiaries
$2,799
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 21,141 Psychiatry providers
+65%
Cost per patient vs peers
$2,799 vs $1,696 avg
+28%
Brand preference vs peers
6.3% vs 5.0% avg
Brand vs Generic
Brand: 550 claims · $1.4M
Generic: 8,114 claims · $307K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Paliperidone Palmitate | 87 | $298K |
| Deutetrabenazine | 25 | $238K |
| Valbenazine Tosylate | 21 | $175K |
| Risperidone | 41 | $110K |
| Paliperidone Palmitate | 15 | $108K |
| Cariprazine Hcl | 61 | $101K |
| Lurasidone Hcl | 33 | $67K |
| Risperidone Microspheres | 28 | $59K |
| Aripiprazole | 17 | $48K |
| Brexpiprazole | 26 | $38K |
| Paliperidone | 65 | $34K |
| Aripiprazole | 297 | $23K |
| Naltrexone Microspheres | 12 | $19K |
| Divalproex Sodium | 182 | $16K |
| Quetiapine Fumarate | 580 | $14K |
Prescribing Profile
70
Unique Drugs
12.0
Anomaly Score
Patient Profile
57
Avg Age
56%
Female
1.64
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About